Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | GCK | P35557 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | PPARG | P37231 | 2/20 | 0.34 |
| ▸ | PPARA | Q07869 | 2/20 | 0.34 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2686642 | 0.80 | PPARA (0.52) | PPARGPPARAL3MBTL1 | |
| SCHEMBL6829427 | 0.77 | MTNR1A (0.43) | PPARGPPARAMTNR1BPTPN1 | |
| SCHEMBL15558253 | 0.77 | L3MBTL1 (0.46) | ACHEMAPTSMN1; SMN2KDM4EGAA | |
| SCHEMBL6055987 | 0.74 | ALDH1A1 (0.47) | MAPTLMNASMN1; SMN2GAAGLA | |
| SCHEMBL6832494 | 0.73 | CA12 (0.41) | MAPTPPARGPPARASMN1; SMN2 | |
| SCHEMBL15547765 | 0.73 | ELANE (0.46) | ACHEMAPTLMNASMN1; SMN2KDM4E | |
| SCHEMBL7617609 | 0.73 | ALDH1A1 (0.46) | MAPTLMNASMN1; SMN2GAAGLA | |
| SCHEMBL7069550 | 0.72 | CA12 (0.40) | PPARGPPARAGAA | |
| SCHEMBL15558679 | 0.72 | ALDH1A1 (0.44) | SMN1; SMN2KDM4EGLAL3MBTL1 | |
| SCHEMBL6065085 | 0.71 | MAPT (0.44) | ACHEMAPTLMNAPTPN1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1399166-A1 | A PHARMACEUTICAL COMBINATION COMPRISING EITHER (S)-2-ETHOXY-3- 4-(2- 4-METHANE SULFONYL OXYPHENYL ETHOXY) PHENYL] PROPANOIC ACID OR 3- 4- 2-(4-TERT- BUTOXY CARBONYL AMINOPHENYL) ETHOXY] PHENYL -(s)-2-ETHOXY PROPANOIC ACID AND A SULONYLUREA | AstraZeneca AB (SE) | 2004-03-24 | — | — | EP | claimed |
| WO-2002100413-A1 | A PHARMACEUTICAL COMBINATION COMPRISING EITHER (S)-2-ETHOXY-3- [4-(2-{4-METHANE SULFONYL OXYPHENYL} ETHOXY) PHENYL] PROPANOIC ACID OR 3-{4-[2-(4-TERT- BUTOXY CARBONYL AMINOPHENYL) ETHOXY] PHENYL} -(s)-2-ETHOXY PROPANOIC ACID AND A SULONYLUREA | ASTRAZENECA AB (SE) | 2002-12-19 | — | — | WO | claimed |